Richard van den Broek
Director/Board Member at COGSTATE LIMITED
Net worth: 4 M $ as of 2024-03-30
Profile
Richard van den Broek founded HSMR Advisors LLC in 2004, where he is working as Managing Partner from 2012.
Mr. van den Broek also currently works at PhaseBio Pharmaceuticals, Inc., as Independent Director from 2019, Cogstate Ltd., as Independent Non-Executive Director from 2010, and Pulse Biosciences, Inc., as Independent Director from 2020.
Mr. van den Broek also formerly worked at Pharmacyclics LLC, as Independent Director from 2009 to 2015, Standard Diversified, Inc., as Independent Director from 2011 to 2015, Syntara Ltd., as Non-Executive Director from 2009 to 2013, Response Genetics, Inc., as Independent Director from 2010 to 2015, Amerisur Resources Ltd., as Non-Executive Director, Celldex Therapeutics, Inc., as Independent Director from 2014 to 2016, Pharmacyclics, Inc., as Director from 2009 to 2015, Cooper Hill Partners LLC (Investment Management), as Partner from 2000 to 2003, and Oppenheimer & Co., Inc., as Biotech Analyst.
Mr. van den Broek received his undergraduate degree from Harvard University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
COGSTATE LTD
2.60% | 2023-06-29 | 4,458,500 ( 2.60% ) | 4 M $ | 2024-03-30 |
PULSE BIOSCIENCES, INC.
-.--% | 2024-03-19 | 0 ( -.--% ) | - $ | 2024-03-30 |
| 2023-05-18 | 0 ( -.--% ) | - $ | 2024-01-30 |
Richard van den Broek active positions
| Companies | Position | Start |
|---|---|---|
| COGSTATE LIMITED | Director/Board Member | 2010-08-25 |
| PHASEBIO PHARMACEUTICALS, INC. | Director/Board Member | 2019-02-26 |
| PULSE BIOSCIENCES, INC. | Director/Board Member | 2020-08-05 |
HSMR Advisors LLC
 HSMR Advisors LLC Investment ManagersFinance HSMR Advisors LLC is an investment fund located in Greenwich, Connecticut | Founder | 2011-02-28 |
Former positions of Richard van den Broek
| Companies | Position | End |
|---|---|---|
| CELLDEX THERAPEUTICS, INC. | Director/Board Member | 2016-11-30 |
| STANDARD DIVERSIFIED INC | Director/Board Member | 2015-10-18 |
| RESPONSE GENETICS, INC | Director/Board Member | 2015-08-31 |
| PHARMACYCLICS, INC. | Director/Board Member | 2015-03-31 |
Pharmacyclics, Inc.
 Pharmacyclics, Inc. Pharmaceuticals: MajorHealth Technology Pharmacyclics, Inc. develops drugs to treat cancer. The private company is based in Sunnyvale, CA. Robert William Duggan has been the CEO of the company since 2015. | Director/Board Member | 2015-03-31 |
Training of Richard van den Broek
| Harvard University | Undergraduate Degree |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 6 |
|---|---|
| PHASEBIO PHARMACEUTICALS, INC. | Health Technology |
| SYNTARA LIMITED | Health Technology |
| COGSTATE LIMITED | Commercial Services |
| RESPONSE GENETICS, INC | Health Technology |
| PULSE BIOSCIENCES, INC. | Health Technology |
| CELLDEX THERAPEUTICS, INC. | Health Services |
| Private companies | 7 |
|---|---|
Pharmacyclics LLC
 Pharmacyclics LLC Pharmaceuticals: MajorHealth Technology Pharmacyclics LLC engages in developing and commercializing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases. It has product candidates in clinical development and several preclinical molecules in optimization. The company was founded by Jonathan Sessler and Richard Miller in 1991 and is headquartered in Sunnyvale, CA. | Health Technology |
Standard Diversified, Inc.
 Standard Diversified, Inc. TobaccoConsumer Non-Durables Standard Diversified, Inc. is a holding company, which owns and operates subsidiaries in a variety of industries, including other tobacco products, insurance, and outdoor advertising. It operates through the following segments: Smokeless Products, Smoking Products, and NewGen Products. The Smokeless Product segment manufactures and markets moist snuff and contracts for and markets chewing tobacco products. The Smoking Products segment imports and markets cigarette papers, tubes, and related products; imports and markets finished cigars, MYO cigar tobaccos, and cigar wraps; and processes, packages, and markets pipe tobaccos. The NewGen Products segment trades e-cigarettes, e-liquids, vaporizers, and other related products; and distributes a wide assortment of vaping products to non-traditional retail outlets via VaporBeast and Vapor Shark. The company was founded by Martha C. Reider, Anne Cavanaugh and Richard C. Birkmeyer in 1990 and is headquartered in New York, NY. | Consumer Non-Durables |
Cooper Hill Partners LLC (Investment Management)
 Cooper Hill Partners LLC (Investment Management) Investment ManagersFinance Cooper Hill Partners LLC is a New York City-based hedge fund manager. | Finance |
Oppenheimer & Co., Inc.
 Oppenheimer & Co., Inc. Investment ManagersFinance Oppenheimer & Co., Inc. provides security brokerage services. It also offers investment banking and advice to high net worth investors, individuals, businesses and institutions. The company is headquartered in New York, NY. | Finance |
HSMR Advisors LLC
HSMR Advisors LLC Investment ManagersFinance HSMR Advisors LLC is an investment fund located in Greenwich, Connecticut | Finance |
Amerisur Resources Ltd.
 Amerisur Resources Ltd. Oil & Gas ProductionEnergy Minerals Amerisur Resources Plc engages in the exploration and production of oil and gas. It operates through the following geographical segments: UK, Colombia, and Paraguay. Its projects include Platanillo, Putumayo-9, Putumayo-12, Putumayo-8, Putumayo-30, Coati Block, CPO-5, Andaquies Block, Terecay, Tacacho, and Mecaya. The company was founded on July 5, 2000 and is headquartered in London, the United Kingdom. | Energy Minerals |
Pharmacyclics, Inc.
Pharmacyclics, Inc. Pharmaceuticals: MajorHealth Technology Pharmacyclics, Inc. develops drugs to treat cancer. The private company is based in Sunnyvale, CA. Robert William Duggan has been the CEO of the company since 2015. | Health Technology |
- Stock Market
- Insiders
- Richard van den Broek
